# Grand Canyon Education, Inc.: financial statements, quarterly

LOPE · Nasdaq · CIK 1434588 · [Other](/sectors/other.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/lope.md) · [Financials](/companies/lope/financials.md) · [Filings](/companies/lope/filings.md) · [Insiders](/companies/lope/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/lope/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [222](/filings/0001558370-24-014620.md) | [278 d](/filings/0001104659-26-017047.md) | [275](/filings/0001558370-25-006495.md) | [227](/filings/0001558370-25-010519.md) | [238](/filings/0001104659-25-106995.md) | [293 d](/filings/0001104659-26-017047.md) | [289](/filings/0001104659-26-052898.md) | [247](/filings/0001104659-26-088674.md) | [261](/filings/0001104659-25-106995.md) | [308 d](/filings/0001104659-26-017047.md) | [309](/filings/0001104659-26-052898.md) | [264](/filings/0001104659-26-088674.md) |
| Operating income | $m | [41.5](/filings/0001558370-24-014620.md) | [97.8 d](/filings/0001104659-26-017047.md) | [84.5](/filings/0001558370-25-006495.md) | [42.7](/filings/0001558370-25-010519.md) | [48.2](/filings/0001104659-25-106995.md) | [100 d](/filings/0001104659-26-017047.md) | [88.0](/filings/0001104659-26-052898.md) | [51.8](/filings/0001104659-26-088674.md) | [18.0](/filings/0001104659-25-106995.md) | [108 d](/filings/0001104659-26-017047.md) | [95.5](/filings/0001104659-26-052898.md) | [58.2](/filings/0001104659-26-088674.md) |
| Interest expense | $m | [0.0](/filings/0001558370-23-017417.md) | [0.0 d](/filings/0001558370-24-001060.md) | [0.0](/filings/0001558370-24-007046.md) | [0.0](/filings/0001558370-25-010519.md) | [0.0 d](/filings/0001558370-24-014620.md) | [0.0 d](/filings/0001558370-25-001150.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [8.5](/filings/0001558370-24-014620.md) | [20.1 d](/filings/0001104659-26-017047.md) | [20.2](/filings/0001558370-25-006495.md) | [12.0](/filings/0001558370-25-010519.md) | [10.9](/filings/0001104659-25-106995.md) | [22.1 d](/filings/0001104659-26-017047.md) | [19.8](/filings/0001104659-26-052898.md) | [13.5](/filings/0001104659-26-088674.md) | [5.4](/filings/0001104659-25-106995.md) | [25.0 d](/filings/0001104659-26-017047.md) | [23.1](/filings/0001104659-26-052898.md) | [15.0](/filings/0001104659-26-088674.md) |
| Net income | $m | [35.7](/filings/0001558370-24-014620.md) | [80.7 d](/filings/0001104659-26-017047.md) | [68.0](/filings/0001558370-25-006495.md) | [34.9](/filings/0001558370-25-010519.md) | [41.5](/filings/0001104659-25-106995.md) | [81.9 d](/filings/0001104659-26-017047.md) | [71.6](/filings/0001104659-26-052898.md) | [41.5](/filings/0001104659-26-088674.md) | [16.3](/filings/0001104659-25-106995.md) | [86.7 d](/filings/0001104659-26-017047.md) | [75.3](/filings/0001104659-26-052898.md) | [45.9](/filings/0001104659-26-088674.md) |
| Diluted EPS | $ per share | [1.19](/filings/0001558370-24-014620.md) | not reported | [2.29](/filings/0001558370-25-006495.md) | [1.19](/filings/0001558370-25-010519.md) | [1.42](/filings/0001104659-25-106995.md) | not reported | [2.52](/filings/0001104659-26-052898.md) | [1.48](/filings/0001104659-26-088674.md) | [0.58](/filings/0001104659-25-106995.md) | not reported | [2.80](/filings/0001104659-26-052898.md) | [1.75](/filings/0001104659-26-088674.md) |
| Basic EPS | $ per share | [1.20](/filings/0001558370-24-014620.md) | not reported | [2.31](/filings/0001558370-25-006495.md) | [1.19](/filings/0001558370-25-010519.md) | [1.43](/filings/0001104659-25-106995.md) | not reported | [2.53](/filings/0001104659-26-052898.md) | [1.48](/filings/0001104659-26-088674.md) | [0.59](/filings/0001104659-25-106995.md) | not reported | [2.82](/filings/0001104659-26-052898.md) | [1.75](/filings/0001104659-26-088674.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [56.9](/filings/0001558370-23-017417.md) | [146](/filings/0001558370-25-001150.md) | [196](/filings/0001558370-24-007046.md) | [241](/filings/0001558370-24-011082.md) | [264](/filings/0001558370-24-014620.md) | [325](/filings/0001104659-26-017047.md) | [145](/filings/0001558370-25-006495.md) | [192](/filings/0001558370-25-010519.md) | [97.3](/filings/0001104659-25-106995.md) | [112](/filings/0001104659-26-088674.md) | [96.1](/filings/0001104659-26-052898.md) | [171](/filings/0001104659-26-088674.md) |
| Current assets | $m | [275](/filings/0001558370-23-017417.md) | [338](/filings/0001558370-25-001150.md) | [444](/filings/0001558370-24-007046.md) | [390](/filings/0001558370-24-011082.md) | [393](/filings/0001558370-24-014620.md) | [420](/filings/0001104659-26-017047.md) | [436](/filings/0001558370-25-006495.md) | [422](/filings/0001558370-25-010519.md) | [434](/filings/0001104659-25-106995.md) | [400](/filings/0001104659-26-088674.md) | [380](/filings/0001104659-26-052898.md) | [331](/filings/0001104659-26-088674.md) |
| Total assets | $m | [863](/filings/0001558370-23-017417.md) | [930](/filings/0001558370-25-001150.md) | [1,036](/filings/0001558370-24-007046.md) | [993](/filings/0001558370-24-011082.md) | [993](/filings/0001558370-24-014620.md) | [1,018](/filings/0001104659-26-017047.md) | [1,031](/filings/0001558370-25-006495.md) | [1,021](/filings/0001558370-25-010519.md) | [1,033](/filings/0001104659-25-106995.md) | [992](/filings/0001104659-26-088674.md) | [968](/filings/0001104659-26-052898.md) | [919](/filings/0001104659-26-088674.md) |
| Current liabilities | $m | [99.5](/filings/0001558370-23-017417.md) | [97.0](/filings/0001558370-25-001150.md) | [160](/filings/0001558370-24-007046.md) | [107](/filings/0001558370-24-011082.md) | [107](/filings/0001558370-24-014620.md) | [111](/filings/0001104659-26-017047.md) | [128](/filings/0001558370-25-006495.md) | [119](/filings/0001558370-25-010519.md) | [137](/filings/0001104659-25-106995.md) | [110](/filings/0001104659-26-088674.md) | [138](/filings/0001104659-26-052898.md) | [118](/filings/0001104659-26-088674.md) |
| Total liabilities | $m | [213](/filings/0001558370-23-017417.md) | [212](/filings/0001558370-25-001150.md) | [276](/filings/0001558370-24-007046.md) | [233](/filings/0001558370-24-011082.md) | [229](/filings/0001558370-24-014620.md) | [235](/filings/0001104659-26-017047.md) | [251](/filings/0001558370-25-006495.md) | [243](/filings/0001558370-25-010519.md) | [275](/filings/0001104659-25-106995.md) | [245](/filings/0001104659-26-088674.md) | [272](/filings/0001104659-26-052898.md) | [250](/filings/0001104659-26-088674.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [651](/filings/0001558370-24-014620.md) | [718](/filings/0001104659-26-017047.md) | [759](/filings/0001104659-25-106995.md) | [759](/filings/0001104659-25-106995.md) | [764](/filings/0001104659-25-106995.md) | [784](/filings/0001104659-26-088674.md) | [781](/filings/0001104659-26-088674.md) | [778](/filings/0001104659-26-088674.md) | [758](/filings/0001104659-25-106995.md) | [747](/filings/0001104659-26-088674.md) | [696](/filings/0001104659-26-088674.md) | [670](/filings/0001104659-26-088674.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(29.9) d](/filings/0001558370-24-014620.md) | [116 d](/filings/0001104659-26-017047.md) | [85.0](/filings/0001558370-25-006495.md) | [98.6 d](/filings/0001558370-25-010519.md) | [(29.4) d](/filings/0001104659-25-106995.md) | [136 d](/filings/0001104659-26-017047.md) | [67.6](/filings/0001104659-26-052898.md) | [124 d](/filings/0001104659-26-088674.md) | [(48.6) d](/filings/0001104659-25-106995.md) | [130 d](/filings/0001104659-26-017047.md) | [88.2](/filings/0001104659-26-052898.md) | [109 d](/filings/0001104659-26-088674.md) |
| Capital expenditure | $m | [16.6 d](/filings/0001558370-24-014620.md) | [10.4 d](/filings/0001104659-26-017047.md) | [9.0](/filings/0001558370-25-006495.md) | [9.0 d](/filings/0001558370-25-010519.md) | [9.6 d](/filings/0001104659-25-106995.md) | [9.7 d](/filings/0001104659-26-017047.md) | [8.9](/filings/0001104659-26-052898.md) | [8.6 d](/filings/0001104659-26-088674.md) | [9.7 d](/filings/0001104659-25-106995.md) | [7.6 d](/filings/0001104659-26-017047.md) | [8.1](/filings/0001104659-26-052898.md) | [10.7 d](/filings/0001104659-26-088674.md) |
| Share repurchases | $m | [33.7 d](/filings/0001558370-24-014620.md) | [16.8 d](/filings/0001104659-26-017047.md) | [30.0](/filings/0001558370-25-006495.md) | [38.7 d](/filings/0001558370-25-010519.md) | [39.6 d](/filings/0001104659-25-106995.md) | [64.8 d](/filings/0001104659-26-017047.md) | [77.9](/filings/0001104659-26-052898.md) | [47.4 d](/filings/0001104659-26-088674.md) | [39.5 d](/filings/0001104659-25-106995.md) | [100 d](/filings/0001104659-26-017047.md) | [128](/filings/0001104659-26-052898.md) | [75.3 d](/filings/0001104659-26-088674.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [31.4](/filings/0001558370-23-017417.md) | [30.6](/filings/0001558370-24-007046.md) | [30.3](/filings/0001558370-24-011082.md) | [29.9](/filings/0001558370-24-014620.md) | [29.6](/filings/0001558370-25-006495.md) | [29.4](/filings/0001558370-25-010519.md) | [29.2](/filings/0001104659-25-106995.md) | [28.5](/filings/0001104659-26-052898.md) | [28.1](/filings/0001104659-26-088674.md) | [27.9](/filings/0001104659-25-106995.md) | [26.9](/filings/0001104659-26-052898.md) | [26.2](/filings/0001104659-26-088674.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 26,065,037 at 2026-07-28, from the cover of the [10-Q filed 2026-07-30](/filings/0001104659-26-088674.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:39 ET. No prices; not investment advice.